Menu Back to Benefit-Risk-Assessment-from-Inception-to-Maturation-Aligning-Regulatory-and-Industry-Goals

Program Committee

  • Kim  McCleary
    Kim McCleary Managing Director
    Fastercures, A Center of the Milken Institute, United States
  • Rebecca A. Noel
    Rebecca A. Noel Global Benefit-Risk Lead, Global Patient Safety
    Eli Lilly and Company, United States
  • Bennett  Levitan
    Bennett Levitan Senior Director, Benefit-Risk Assessment, Department of Epidemiology
    Janssen Research & Development, LLC, United States
  • Marilyn A. Metcalf, PhD
    Marilyn A. Metcalf, PhD Senior Director, Benefit-Risk Evaluation
    GlaxoSmithKline, United States
  • Lawrence Eugene Liberti, MS, RPh, RAC
    Lawrence Eugene Liberti, MS, RPh, RAC Executive Director
    Centre For Innovation In Regulatory Science (CIRS), United States
Load More